JP2024541089A5 - - Google Patents

Info

Publication number
JP2024541089A5
JP2024541089A5 JP2024529509A JP2024529509A JP2024541089A5 JP 2024541089 A5 JP2024541089 A5 JP 2024541089A5 JP 2024529509 A JP2024529509 A JP 2024529509A JP 2024529509 A JP2024529509 A JP 2024529509A JP 2024541089 A5 JP2024541089 A5 JP 2024541089A5
Authority
JP
Japan
Prior art keywords
scn11a
variant
nucleic acid
acid molecule
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024529509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024541089A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/080208 external-priority patent/WO2023092112A1/en
Publication of JP2024541089A publication Critical patent/JP2024541089A/ja
Publication of JP2024541089A5 publication Critical patent/JP2024541089A5/ja
Pending legal-status Critical Current

Links

JP2024529509A 2021-11-20 2022-11-21 ナトリウム電位依存性チャネルαサブユニット11(SCN11A)阻害剤による頭痛及び片頭痛の治療方法 Pending JP2024541089A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163281640P 2021-11-20 2021-11-20
US63/281,640 2021-11-20
PCT/US2022/080208 WO2023092112A1 (en) 2021-11-20 2022-11-21 Methods of treating headaches and migraines with sodium voltage-gated channel alpha subunit 11 (scn11a) inhibitors

Publications (2)

Publication Number Publication Date
JP2024541089A JP2024541089A (ja) 2024-11-06
JP2024541089A5 true JP2024541089A5 (https=) 2025-11-20

Family

ID=84829809

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529509A Pending JP2024541089A (ja) 2021-11-20 2022-11-21 ナトリウム電位依存性チャネルαサブユニット11(SCN11A)阻害剤による頭痛及び片頭痛の治療方法

Country Status (10)

Country Link
US (1) US20230279400A1 (https=)
EP (1) EP4433090A1 (https=)
JP (1) JP2024541089A (https=)
KR (1) KR20240109247A (https=)
CN (1) CN118234513A (https=)
AU (1) AU2022393586A1 (https=)
CA (1) CA3237033A1 (https=)
IL (1) IL312312A (https=)
MX (1) MX2024006042A (https=)
WO (1) WO2023092112A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025037925A1 (ko) 2023-08-16 2025-02-20 주식회사 엘지에너지솔루션 이차전지용 양극 및 이를 포함하는 이차전지

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US96183A (en) * 1869-10-26 Improved ciiothes-mne supporter
EP2769724A1 (en) * 2013-02-22 2014-08-27 Université d'Aix-Marseille Inhibitors of Na(v) 1.9 channel activity and uses thereof for treating pain
US9139648B1 (en) * 2014-07-15 2015-09-22 Kymab Limited Precision medicine by targeting human NAV1.9 variants for treatment of pain
JP6782412B2 (ja) * 2014-11-25 2020-11-11 国立大学法人京都大学 疼痛遺伝子及びその用途
CN108530534B (zh) * 2017-03-03 2021-06-18 易森荟(武汉)生物医药有限公司 Nav1.9的靶点多肽、与其结合的抗体及抗体片段和相关药物组合物

Similar Documents

Publication Publication Date Title
Pariollaud et al. Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation
Liu et al. Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice
Hou et al. Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways
Chandel et al. Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin
Skendros et al. Regulated in development and DNA damage responses 1 (REDD1) links stress with IL-1β–mediated familial Mediterranean fever attack through autophagy-driven neutrophil extracellular traps
Pereira et al. Rosiglitazone and 15-deoxy-Δ12, 14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms
Wehbi et al. Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors
Zhao et al. Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury
Sumida et al. Complement C1q-induced activation of β-catenin signalling causes hypertensive arterial remodelling
Tipsmark et al. Salinity regulates claudin mRNA and protein expression in the teleost gill
Terenzi et al. Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium
Gong et al. Paired related homeobox protein 1 regulates PDGF-induced chemotaxis of hepatic stellate cells in liver fibrosis
Yokota et al. STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model
Liu et al. PTK7 regulates Id1 expression in CD44-high glioma cells
Guo et al. Transient receptor potential Vanilloid 1-based gene therapy alleviates orthodontic pain in rats
WO2008011603A2 (en) Modulating notch1 signaling pathway for treating neuroendocrine tumors
Zhao et al. Disturbing NLRP3 acetylation and inflammasome assembly inhibits androgen receptor‐promoted inflammatory responses and prostate cancer progression
Siddiqi et al. CXCR4 promotes renal tubular cell survival in male diabetic rats: implications for ligand inactivation in the human kidney
Fang et al. Molecular basis of Cav2. 3 calcium channels in rat nociceptive neurons
Zhou et al. Disruption of CXCR3 function impedes the development of Sjögren’s syndrome-like xerostomia in non-obese diabetic mice
Suzuki et al. Tissue accumulation of neutrophil extracellular traps mediates muscle hyperalgesia in a mouse model
Chen et al. Protective effect of RNase on unilateral nephrectomy-induced postoperative cognitive dysfunction in aged mice
Nakamura et al. HIF-1α and MIF enhance neutrophil-driven type 3 immunity and chondrogenesis in a murine spondyloarthritis model
JP2024541089A5 (https=)
JP2026053561A (ja) 循環からミトコンドリアdna又はゲノムdnaを枯渇させることにより疾患及び症状を治療する組成物及び方法